Tamer I. Khayal - 23 Feb 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Commercial Officer
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 23 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 27 Feb 2024, 17:00:38 UTC
Previous filing: 21 Feb 2024
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+12,127	+84%	$0.000000	26,502	23 Feb 2024	Direct	F1
holding	TMDX	Common Stock						14,776	23 Feb 2024	By the Khayal Family 2021 Irrevocable Trust
holding	TMDX	Common Stock						11,051	23 Feb 2024	By the Tamer Ibrahim Ahmed Khayal Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+18,690		$0.000000	18,690	23 Feb 2024	Common Stock	18,690	$83.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 12,127 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service.